Medivation

Medivation Files Enzalutamide NDA
Yahoo/Zacks
Tue, 05/22/12 - 11:16 am
Medivation
Astellas
prostate cancer
Enzalutamide
What You Must Know Before Investing in Prostate Cancer Stocks
Minyanville
Mon, 05/21/12 - 12:22 pm
prostate cancer
Dendreon
Cougar Biotechnology
JNJ
Medivation
Exelixis
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells
Seeking Alpha
Sat, 05/19/12 - 12:36 pm
Halozyme
Novavax
Prolor
Valeant Pharmaceuticals
Myrexis
OPKO Health
Vertex Pharmaceuticals
Edwards Lifesciences
Medivation
Biomarin
Mylan
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Pfizer, Johnson & Johnson, Ariad, and Medivation in Spotlight at Cancer Meeting
Minyanville
Wed, 05/16/12 - 10:53 am
ASCO
Pfizer
JNJ
Ariad Pharmaceuticals
Medivation
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Dendreon May See Massive Gains By 2013 On Provenge
Seeking Alpha
Fri, 04/13/12 - 08:29 am
Dendreon
Provenge
JNJ
Medivation
prostate cancer
Immunogen
Seattle Genetics
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Seattle Genetics
Celldex
Arqule
Daiichi Sankyo
JNJ
Medivation
Dendreon
Aveo Pharmaceutical
Ariad Pharmaceuticals
AstraZeneca
Array Biopharma
Oncothyreon
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thu, 03/8/12 - 10:15 am
JNJ
prostate cancer
Dendreon
Provenge
Medivation
Zytiga
MDV3100
Medivation says prostate cancer pill MDV3100 met goal in second clinical trial
Yahoo/AP
Wed, 02/1/12 - 12:21 pm
Medivation
prostate cancer
MDV3100
Medivation Shrugs Off Alzheimer's Setback as Investors Eye New Prostate Cancer Data
TheStreet.com
Tue, 01/17/12 - 11:32 am
Medivation
prostate cancer
Alzheimer's disease
MDV3100
Pfizer, Medivation end development of potential Alzheimer's treatment dimebon
Yahoo/AP
Tue, 01/17/12 - 10:06 am
Pfizer
Medivation
Alzheimer's disease
dimebon
Biotechs: Has The Law Of Gravity Been Suspended?
Seeking Alpha
Sat, 01/14/12 - 11:27 am
Celgene
Dendreon
Medivation
Regeneron
ViroPharma
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
Five Drug Stock Winners of 2011
TheStreet.com
Mon, 12/19/11 - 10:01 am
Inhibitex
Questcor
Medivation
Pharmasset
Pharmacyclics
3 Biotech Stocks You Should Sell Before 2012
Seeking Alpha
Thu, 12/8/11 - 11:34 am
Isis Pharmaceuticals
MannKind
Medivation
3 Rallying Healthcare Stocks With Bullish Short Trends
Seeking Alpha
Sun, 11/27/11 - 12:07 pm
Biomarin
Questcor Pharmaceuticals
Medivation
Medivation Back to Neutral
Yahoo/Zacks
Sat, 11/26/11 - 10:22 am
Medivation
MDV3100
prostate cancer
11 Biotech Stocks With Bullish Short Trends
Seeking Alpha
Wed, 11/23/11 - 11:14 am
Biomarin
BioSpecifics Technologies
Complete Genomics
Incyte
Medivation
Insmed
Momenta
Questcor
Seattle Genetics
Sangamo BioSciences
XenoPort
3 Cancer Immunotherapy Biotechs With Catalysts For 2012
Seeking Alpha
Thu, 11/17/11 - 09:03 am
Alnylam
Dendreon
GSK
Medivation
ImmunoCellular
Novartis
cancer
NewLink Genetics

Pages